×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Lactose Intolerance Treatment Market Share

ID: MRFR/Pharma/2581-CR
133 Pages
Rahul Gotadki
March 2019

Lactose Intolerance Treatment Market Research Report Information By Type (Lactose Intolerance, Secondary Lactose Intolerance, Congenital Lactose Intolerance), By Treatment (Food Supplements, Enzyme Lactase Supplements, Probiotics), By Form (Powder, Liquid and Tablets), By End User (Homecare and Hospitals & Clinics) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Lactose Intolerance Treatment Market Infographic
×
Lactose Intolerance Treatment Market Infographic Full View
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Share

Lactose Intolerance Treatment Market Share Analysis

To maintain and enhance their market share, players in the lactose intolerance treatment market employ different strategies. Differentiation is seen as a major strategy where each company strives to develop sophisticated and improved products for lactase deficiency. Such alternative treatments may include newly developed enzyme supplements, dietary solutions, and probiotics that help in digestion and minimize symptoms caused by lactose intolerance. Cost leadership continues to play an important role within the Lactose Intolerance Treatment Market. This way, companies will be able to optimize their manufacturing processes, hence reducing costs incurred during production while making cost-effective therapies for patients with lactose intolerance. Niche positioning could be observed as many players are serving specific categories of patients within this industry niche. While adapting their lactose intolerance treatments to suit regional diets, health needs, and regulations, geographical positioning is an important strategic consideration. An understanding of local healthcare ecosystems and adherence of products to regional guidelines facilitates effective market penetration. The Lactose Intolerance Treatment Market also heavily relies on collaboration and partnerships, which enable the companies to join hands in order to improve their abilities as well as the expansion of their markets. Collaboration may also include working with physicians, nutritionists, or other organizations specializing in digestion health to develop and validate new lactose intolerance therapies together. By combining strengths and resources, firms can foster innovation, enlarge their product portfolios, and gain a more solid grip on ongoing transformation in the field of digestive wellbeing. Mergers and acquisitions are strategic moves that shape the competitive landscape of the Lactose Intolerance Treatment Market. Acquisitions enable companies to access complementary technologies, expand their IP portfolio, or reinforce their position as leading providers of lactose intolerance treatment approaches. Continuous innovation is a key driver behind the lactose intolerance treatment market; thus, research on new enzyme formulations for dietary supplements and companies undertake personalized treatment measures. Being at par with technological advancements enables them to respond better to changing challenges regarding digestive health conditions alongside regulatory requirements besides market trends. Companies also gain a reputation among stakeholders by adhering to this kind of strategy, which ensures that they remain relevant within lactase-intolerant populations.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the valuation of the market?

lactose intolerance treatment market is expected to be valued at more than USD 26.12 billion by 2030.

What is the CAGR of the market?

The global market is expected to exhibit a strong 5.90% CAGR over the forecast period from 2023 to 2030.

What is the major driver for the market?

The growing prevalence of lactose intolerance is the major driver for the market.

Which is the leading regional market?

Europe held a dominant 42% share in the global lactose intolerance treatment market in 2018.

What are the key players in the market?

Leading players in the market include Abbott, Nestle, and Cargill Inc., among others.

Market Summary

As per MRFR analysis, the Lactose Intolerance Treatment Market Size was estimated at 28.27 USD Billion in 2024. The Lactose Intolerance Treatment industry is projected to grow from 31.18 USD Billion in 2025 to 74.38 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 9.15 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Lactose Intolerance Treatment Market is experiencing dynamic growth driven by evolving consumer preferences and technological advancements.

  • The market is witnessing a rise in personalized nutrition, catering to individual dietary needs. North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region. Lactase supplements dominate the market, whereas probiotics are gaining traction as the fastest-growing segment. Growing awareness of lactose intolerance and the expansion of lactose-free product offerings are key drivers of market growth.

Market Size & Forecast

2024 Market Size 28.27 (USD Billion)
2035 Market Size 74.38 (USD Billion)
CAGR (2025 - 2035) 9.15%
Largest Regional Market Share in 2024 North America

Major Players

Lactaid (US), Danone (FR), Nestle (CH), Abbott Laboratories (US), Pinnacle Foods (US), Arla Foods (DK), Lactose Free (US), Schreiber Foods (US), Fonterra (NZ)

Market Trends

The Lactose Intolerance Treatment Market is currently experiencing notable transformations driven by evolving consumer preferences and advancements in medical research. As awareness of lactose intolerance increases, individuals are actively seeking effective solutions to manage their symptoms. This growing demand has prompted the development of innovative treatment options, including enzyme supplements and lactose-free products.

Furthermore, the market is witnessing a shift towards natural and organic alternatives, as consumers become more health-conscious and prefer products with fewer artificial ingredients. This trend suggests a potential for growth in the market as manufacturers adapt to these changing consumer needs. In addition, the Lactose Intolerance Treatment Market is influenced by the rising prevalence of lactose intolerance across various demographics.

This condition is not limited to specific age groups or regions, leading to a broader target audience for treatment options. As healthcare providers increasingly recognize the importance of addressing lactose intolerance, there is a growing emphasis on education and awareness initiatives. These efforts aim to inform individuals about available treatments and encourage them to seek appropriate care. Overall, the Lactose Intolerance Treatment Market appears poised for continued expansion as it responds to the dynamic landscape of consumer demands and healthcare advancements.

Rise of Personalized Nutrition

The Lactose Intolerance Treatment Market is witnessing a trend towards personalized nutrition, where treatments are tailored to individual dietary needs. This approach allows for more effective management of lactose intolerance symptoms, as consumers seek solutions that align with their unique health profiles. Companies are increasingly focusing on developing customized enzyme supplements and dietary plans that cater to specific consumer preferences.

Increased Demand for Dairy Alternatives

There is a growing interest in dairy alternatives among consumers, which is significantly impacting the Lactose Intolerance Treatment Market. As more individuals adopt plant-based diets or seek lactose-free options, the market for dairy substitutes is expanding. This trend indicates a shift in consumer behavior, as people prioritize health and sustainability in their dietary choices.

Technological Advancements in Treatment

Technological innovations are playing a crucial role in the evolution of the Lactose Intolerance Treatment Market. New research and development efforts are leading to the creation of more effective enzyme supplements and diagnostic tools. These advancements not only enhance treatment efficacy but also improve the overall consumer experience, making it easier for individuals to manage their lactose intolerance.

Lactose Intolerance Treatment Market Market Drivers

Growing Health Consciousness

A surge in health consciousness among consumers significantly influences the Global Lactose Intolerance Treatment Market Industry. Individuals are increasingly prioritizing their dietary choices, leading to a demand for lactose-free products and treatments. This trend is particularly evident in developed regions, where consumers are more informed about dietary restrictions and their implications on health. As a result, the market is expected to experience a compound annual growth rate of 6.58% from 2025 to 2035, with projections indicating a market size of 34.8 USD Billion by 2035. This shift underscores the importance of lactose intolerance management in contemporary dietary practices.

Innovations in Lactose-Free Products

Innovations in lactose-free products are reshaping the Global Lactose Intolerance Treatment Market Industry. Manufacturers are increasingly developing a variety of lactose-free dairy products, such as milk, cheese, and yogurt, catering to the diverse preferences of lactose-intolerant consumers. These innovations not only enhance product availability but also improve taste and nutritional value, making lactose-free options more appealing. The introduction of fortified lactose-free products further supports the market's growth, as consumers seek alternatives that align with their health goals. This trend is likely to sustain the market's expansion in the coming years.

Rising Demand for Personalized Nutrition

The rising demand for personalized nutrition is influencing the Global Lactose Intolerance Treatment Market Industry. Consumers are increasingly seeking tailored dietary solutions that address their specific health needs, including lactose intolerance. This trend is prompting manufacturers to develop customized lactose-free products and treatments that cater to individual preferences and dietary restrictions. As personalized nutrition gains traction, the market is likely to see a surge in innovative offerings that align with consumer demands. This shift towards individualized dietary solutions may further enhance the market's growth trajectory in the coming years.

Rising Prevalence of Lactose Intolerance

The increasing prevalence of lactose intolerance globally drives the Global Lactose Intolerance Treatment Market Industry. Approximately 68% of the world's population experiences some form of lactose malabsorption, with higher rates observed in certain ethnic groups. This growing awareness of lactose intolerance leads to a heightened demand for treatment options, including lactase supplements and lactose-free products. As more individuals seek solutions to manage their symptoms, the market is projected to reach 17.3 USD Billion in 2024, reflecting a significant shift in consumer behavior towards lactose-free alternatives.

Increased Availability of Lactase Supplements

The increased availability of lactase supplements is a key driver in the Global Lactose Intolerance Treatment Market Industry. These supplements provide a convenient solution for individuals who wish to enjoy dairy products without experiencing discomfort. As awareness of lactose intolerance grows, more consumers are turning to lactase supplements as a proactive measure. Pharmacies and health food stores are expanding their offerings, making these products more accessible. This trend is anticipated to contribute to the market's growth, as consumers increasingly seek effective solutions to manage their lactose intolerance symptoms.

Market Segment Insights

By Treatment Type: Lactase Supplements (Largest) vs. Probiotics (Fastest-Growing)

In the Lactose Intolerance Treatment Market, Lactase Supplements are currently the largest segment, catering to a significant portion of consumers seeking immediate relief from lactose intolerance symptoms. Following closely, Probiotics represent the fastest-growing segment, driven by increased awareness of gut health and the holistic benefits of probiotics in managing lactose intolerance. Dietary Modifications and Enzyme Replacement Therapy also contribute to the landscape, with their specific niches appealing to distinct consumer preferences. The growth trends in this segment are influenced by a rising trend in health consciousness and the demand for natural products. Lactase Supplements maintain a strong consumer base due to their direct efficacy, while Probiotics are gaining momentum as they align with the growing trend towards natural and preventive healthcare and dietary approaches. Additionally, increased consumer education regarding lactose intolerance has broadened the understanding and acceptance of various treatment types, fueling growth in these areas.

Lactase Supplements (Dominant) vs. Probiotics (Emerging)

Lactase Supplements are the dominant treatment for lactose intolerance, providing direct and effective relief from symptoms. The segment appeals to consumers seeking quick solutions to their digestive challenges and is backed by a robust supply chain and distribution network that enhances accessibility. On the other hand, Probiotics are emerging as a key player within this market segment, thanks to their increasing association with gut health and overall well-being. This segment attracts health-conscious consumers looking for natural alternatives to manage lactose intolerance. Probiotics not only help in digesting lactose more effectively but also support gut flora, making them appealing to a broader audience beyond just those with lactose intolerance. Their growing popularity is further fueled by endorsements from health professionals and an increasing array of product offerings tailored to this condition.

By Distribution Channel: Pharmacies (Largest) vs. Online Retail (Fastest-Growing)

The Lactose Intolerance Treatment Market showcases a diverse distribution channel landscape, with pharmacies holding the largest market share. Pharmacies remain a crucial point for consumers seeking treatment, offering a range of products and personalized advice from pharmacists. In contrast, online retail has emerged as a significant platform, quickly gaining traction among consumers due to convenience and accessibility of lactose intolerance treatments from the comfort of their homes. Growth trends in this segment have been driven by increasing awareness of lactose intolerance and the rising demand for suitable dietary options. The online retail channel is particularly thriving, capitalizing on shifts in consumer purchasing habits towards e-commerce. Additionally, supermarkets and health food stores are adapting to this trend by expanding their lactose-free product offerings, catering to the growing health-conscious consumer base, thereby driving overall growth in the market.

Pharmacies (Dominant) vs. Online Retail (Emerging)

Pharmacies represent the dominant distribution channel in the Lactose Intolerance Treatment Market, offering a wide variety of lactose-free products and the benefit of professional guidance from pharmacists. This channel's strong customer trust and accessibility make it an essential go-to for consumers managing lactose intolerance. On the other hand, online retail is emerging rapidly, capturing a growing segment of the market as consumers increasingly prefer the convenience and discretion of shopping online. With a broad selection of treatment options often at competitive prices, online platforms are appealing to a tech-savvy demographic that values speed and ease. This dynamic demonstrates a significant shift in consumer behavior, highlighting the importance of both channels in catering to diverse needs within the lactose intolerance community.

By Patient Demographics: Adults (Largest) vs. Children (Fastest-Growing)

The 'Lactose Intolerance Treatment Market' showcases a diverse demographic segmentation, prominently featuring adults as the largest segment. Adults typically encompass a wide age range and represent a significant proportion of individuals suffering from lactose intolerance, driven by dietary habits and increased awareness of lactose-related health issues. Conversely, the children segment is emerging rapidly due to heightened parental awareness regarding lactose intolerance in young ones, leading to increased demand for specialized treatment and dietary products specifically designed for this age group. Growth trends in the 'Patient Demographics' segment are significantly influenced by educational efforts aimed at recognizing lactose intolerance symptoms and available treatments. The adult demographic benefits from an array of treatment options including lactase supplements and lactose-free products. Meanwhile, the growing awareness among parents of young children regarding health choices has made children the fastest-growing demographic due to rising incidents of lactose intolerance detected in pediatric populations. Increased research into dietary habits during childhood further supports this trend, highlighting the need for tailored lactose intolerance solutions for children.

Adults (Dominant) vs. Children (Emerging)

The adult segment in the lactose intolerance treatment market is characterized by a mature consumer base with established treatment preferences, such as lactase enzyme supplements and lactose-free dairy products. Adults are often more proactive in seeking solutions for managing their symptoms, leading to consistent demand for a wider range of lactose-free options. On the other hand, the children segment presents a unique and emerging market opportunity. With parents increasingly recognizing the implications of lactose intolerance on their children's health, products targeting this demographic are gaining traction. The need for palatable, nutrient-enriched lactose-free products tailored for children is growing, positioning this segment as a focal point for innovation and marketing efforts in the coming years.

By Formulation Type: Tablets (Largest) vs. Powders (Fastest-Growing)

In the Lactose Intolerance Treatment Market, formulation types such as tablets, powders, liquids, and chewables each serve distinct consumer preferences and needs. Tablets dominate the market due to their convenience and ease of dosage, capturing the largest share among all formulation types. On the other hand, powders also play a significant role and are gaining traction rapidly, attributed to their versatility and suitability for various preparation methods, appealing especially to consumers looking for customized solutions for managing lactose intolerance. The growth trends in this segment are influenced by increased awareness regarding lactose intolerance and a rising demand for effective and user-friendly treatment options. Tablets are preferred by individuals seeking a straightforward and portable solution. However, the powder formulation is emerging as a popular choice among health-conscious consumers who favor flexibility in dosage and the ability to incorporate treatments into their daily routines, thus driving significant growth in this category.

Tablets (Dominant) vs. Powders (Emerging)

Tablets remain the dominant formulation type in the Lactose Intolerance Treatment Market due to their straightforward application and consumer familiarity. They are widely trusted for their convenience and efficacy, allowing for precise dosages that cater to varying levels of lactose intolerance. Conversely, powders represent an emerging category, appealing to a segment of the market that values customization and flexibility. Their ability to be mixed into various formulations—be it drinks, foods, or snacks—positions them favorably among consumers looking for personalized treatment solutions. Furthermore, the increasing popularity of self-care and wellness trends contributes to the rising demand for powders, as consumers prioritize adaptable options that fit seamlessly into their lifestyles.

Get more detailed insights about Lactose Intolerance Treatment Market Research Report - Global Forecast till 2035

Regional Insights

North America : Market Leader in Treatments

North America leads the Lactose Intolerance Treatment Market, holding a significant share of 12.0 in 2024. The region's growth is driven by increasing awareness of lactose intolerance and a rising demand for lactose-free products. Regulatory support for food labeling and health claims further catalyzes market expansion. The prevalence of lactose intolerance among various demographics fuels the demand for innovative treatment options, including dietary supplements and lactose-free dairy products. The competitive landscape in North America is robust, featuring key players such as Lactaid, Abbott Laboratories, and Pinnacle Foods. These companies are investing in research and development to enhance product offerings and cater to diverse consumer needs. The U.S. remains the largest market, with Canada and Mexico also contributing to growth. The presence of established brands and a well-developed distribution network ensures that lactose intolerance treatments are widely accessible to consumers.

Europe : Growing Demand for Alternatives

Europe's Lactose Intolerance Treatment Market is valued at 9.0, reflecting a growing demand for lactose-free alternatives. Factors such as increasing health consciousness and dietary preferences are driving this trend. Regulatory frameworks in the EU promote transparency in food labeling, encouraging consumers to opt for lactose-free products. The rise in lactose intolerance awareness among the population is also a significant growth driver, leading to a surge in product innovation and availability. Leading countries in this region include Germany, France, and the UK, where major players like Danone and Nestle are actively expanding their product lines. The competitive landscape is characterized by a mix of established brands and emerging companies focusing on lactose-free solutions. The market is witnessing collaborations and partnerships aimed at enhancing product distribution and consumer reach. "The European market for lactose-free products is expected to grow significantly due to changing consumer preferences and health trends," European Food Safety Authority.

Asia-Pacific : Emerging Market Potential

The Asia-Pacific Lactose Intolerance Treatment Market, valued at 5.0, is witnessing rapid growth driven by increasing awareness of lactose intolerance and dietary changes. Countries like China and India are experiencing a rise in lactose-free product consumption due to changing lifestyles and dietary habits. Regulatory initiatives aimed at improving food safety and labeling are also contributing to market growth, as consumers seek healthier options. The competitive landscape in this region is evolving, with both local and international players entering the market. Companies like Fonterra are expanding their presence, while local brands are innovating to meet consumer needs. The growing middle class and urbanization are further propelling demand for lactose-free products, making Asia-Pacific a key region for future growth in the lactose intolerance treatment market.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa Lactose Intolerance Treatment Market, valued at 2.27, is still in its nascent stages but presents significant growth opportunities. The increasing prevalence of lactose intolerance, coupled with rising health awareness, is driving demand for lactose-free products. Regulatory bodies are beginning to implement guidelines for food labeling, which is expected to enhance consumer trust and product adoption in the region. Countries like South Africa and the UAE are leading the way in market development, with local and international brands exploring opportunities to introduce lactose-free options. The competitive landscape is gradually evolving, with companies focusing on education and awareness campaigns to inform consumers about lactose intolerance. As the market matures, the presence of key players will likely increase, fostering innovation and product diversity.

Key Players and Competitive Insights

The Lactose Intolerance Treatment Market is currently characterized by a dynamic competitive landscape, driven by increasing consumer awareness and demand for lactose-free products. Key players such as Lactaid (US), Danone (FR), and Abbott Laboratories (US) are strategically positioning themselves through innovation and product diversification. Lactaid (US) has focused on expanding its product line to include lactose-free dairy alternatives, which appears to resonate well with health-conscious consumers. Meanwhile, Danone (FR) has been enhancing its portfolio with plant-based options, indicating a shift towards more sustainable and health-oriented products. Abbott Laboratories (US) is leveraging its strong research and development capabilities to introduce advanced lactose-free formulations, thereby enhancing its competitive edge in the market.
The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to meet regional demands effectively. The market structure is moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Lactaid (US) and Danone (FR) is significant, as they set trends that smaller players often follow. This competitive environment fosters innovation and encourages companies to differentiate their offerings, which is crucial in a market where consumer preferences are rapidly evolving.
In November 2025, Lactaid (US) launched a new line of lactose-free yogurt products aimed at younger consumers, which is a strategic move to capture a growing demographic that prioritizes health and wellness. This initiative not only broadens their product range but also positions Lactaid (US) as a leader in the lactose-free segment, appealing to a market that increasingly values convenience and health benefits. The introduction of these products is likely to enhance brand loyalty and attract new customers seeking lactose-free options.
In October 2025, Danone (FR) announced a partnership with a leading technology firm to develop AI-driven solutions for personalized nutrition. This collaboration is expected to enhance Danone's ability to tailor its lactose-free offerings to meet specific consumer needs, thereby increasing customer satisfaction and engagement. The integration of AI into product development signifies a forward-thinking approach that could redefine how lactose-free products are marketed and consumed.
In September 2025, Abbott Laboratories (US) unveiled a new lactose-free infant formula that incorporates advanced nutritional science. This product launch is particularly significant as it addresses a critical gap in the market for lactose-intolerant infants, showcasing Abbott's commitment to innovation and its focus on specialized nutritional needs. By catering to this niche segment, Abbott Laboratories (US) is likely to strengthen its market position and enhance its reputation as a leader in nutritional solutions.
As of December 2025, current trends in the Lactose Intolerance Treatment Market are increasingly defined by digitalization, sustainability, and the integration of advanced technologies. Strategic alliances among key players are shaping the competitive landscape, fostering collaboration that enhances product offerings and market reach. The shift from price-based competition to a focus on innovation and technology is evident, as companies strive to differentiate themselves through unique product features and reliable supply chains. Looking ahead, competitive differentiation will likely evolve further, with an emphasis on sustainability and consumer-centric innovations becoming paramount in shaping the future of the market.

Key Companies in the Lactose Intolerance Treatment Market include

Industry Developments

  • Q2 2024: Danone launches new dairy-free probiotic supplement for lactose intolerance Danone announced the launch of a new dairy-free probiotic supplement specifically formulated to aid individuals with lactose intolerance, expanding its health-focused product portfolio.
  • Q1 2024: Nestlé Health Science introduces expanded range of lactose-free nutritional products Nestlé Health Science unveiled an expanded line of lactose-free nutritional products targeting consumers with lactose intolerance, aiming to strengthen its position in the specialized nutrition market.
  • Q2 2024: Lactaid opens new manufacturing facility in Ohio to meet rising demand Lactaid, a leading brand in lactose-free dairy products, inaugurated a new manufacturing facility in Ohio to increase production capacity and address growing consumer demand for lactose intolerance solutions.
  • Q3 2024: Johnson & Johnson acquires biotech startup developing enzyme therapy for lactose intolerance Johnson & Johnson completed the acquisition of a biotechnology startup focused on developing novel enzyme therapies for lactose intolerance, aiming to enhance its gastrointestinal health portfolio.
  • Q2 2025: Abbott receives FDA approval for new lactose intolerance diagnostic kit Abbott announced that it has received FDA approval for its new diagnostic kit designed to rapidly detect lactose intolerance in clinical settings.
  • Q1 2025: Arla Foods partners with biotech firm to develop next-generation lactase supplements Arla Foods entered into a strategic partnership with a biotechnology company to co-develop advanced lactase enzyme supplements for improved lactose digestion.
  • Q2 2024: GSK launches chewable lactase tablets for children with lactose intolerance GlaxoSmithKline introduced a new line of chewable lactase tablets formulated for pediatric use, targeting children diagnosed with lactose intolerance.
  • Q3 2024: Chobani debuts plant-based yogurt line for lactose-intolerant consumers Chobani launched a new plant-based yogurt line specifically marketed to consumers with lactose intolerance, expanding its alternative dairy offerings.
  • Q1 2025: LactEase files for IPO to fund expansion of lactose intolerance treatment products LactEase, a company specializing in lactose intolerance treatment products, filed for an initial public offering to raise capital for product development and market expansion.
  • Q2 2025: DSM secures EU regulatory approval for novel lactase enzyme supplement DSM received regulatory approval from the European Union for its new lactase enzyme supplement, enabling commercial distribution across EU member states.

Future Outlook

Lactose Intolerance Treatment Market Future Outlook

The Lactose Intolerance Treatment Market is projected to grow at a 9.15% CAGR from 2025 to 2035, driven by increasing consumer awareness and innovative product development.

New opportunities lie in:

  • Expansion of personalized lactose-free product lines
  • Development of mobile health applications for dietary management
  • Investment in educational campaigns targeting lactose intolerance awareness

By 2035, the market is expected to be robust, reflecting significant growth and innovation.

Market Segmentation

Lactose Intolerance Treatment Market Treatment Type Outlook

  • Lactase Supplements
  • Probiotics
  • Dietary Modifications
  • Enzyme Replacement Therapy

Lactose Intolerance Treatment Market Formulation Type Outlook

  • Tablets
  • Powders
  • Liquids
  • Chewables

Lactose Intolerance Treatment Market Distribution Channel Outlook

  • Pharmacies
  • Online Retail
  • Supermarkets
  • Health Food Stores

Lactose Intolerance Treatment Market Patient Demographics Outlook

  • Children
  • Adults
  • Elderly
  • Pregnant Women

Report Scope

MARKET SIZE 2024 28.27(USD Billion)
MARKET SIZE 2025 31.18(USD Billion)
MARKET SIZE 2035 74.38(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 9.15% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Lactaid (US), Danone (FR), Nestle (CH), Abbott Laboratories (US), Pinnacle Foods (US), Arla Foods (DK), Lactose Free (US), Schreiber Foods (US), Fonterra (NZ)
Segments Covered Treatment Type, Distribution Channel, Patient Demographics, Formulation Type
Key Market Opportunities Emerging plant-based alternatives and personalized treatments drive growth in the Lactose Intolerance Treatment Market.
Key Market Dynamics Rising consumer awareness drives demand for lactose-free products, influencing treatment options and market competition.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the valuation of the market?

lactose intolerance treatment market is expected to be valued at more than USD 26.12 billion by 2030.

What is the CAGR of the market?

The global market is expected to exhibit a strong 5.90% CAGR over the forecast period from 2023 to 2030.

What is the major driver for the market?

The growing prevalence of lactose intolerance is the major driver for the market.

Which is the leading regional market?

Europe held a dominant 42% share in the global lactose intolerance treatment market in 2018.

What are the key players in the market?

Leading players in the market include Abbott, Nestle, and Cargill Inc., among others.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | 1.1.1 Market Overview
    3. | 1.1.2 Key Findings
    4. | 1.1.3 Market Segmentation
    5. | 1.1.4 Competitive Landscape
    6. | 1.1.5 Challenges and Opportunities
    7. | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | 2.1.1 Definition
    3. | 2.1.2 Scope of the study
    4. |-- 2.1.2.1 Research Objective
    5. |-- 2.1.2.2 Assumption
    6. |-- 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | 2.2.1 Overview
    9. | 2.2.2 Data Mining
    10. | 2.2.3 Secondary Research
    11. | 2.2.4 Primary Research
    12. |-- 2.2.4.1 Primary Interviews and Information Gathering Process
    13. |-- 2.2.4.2 Breakdown of Primary Respondents
    14. | 2.2.5 Forecasting Model
    15. | 2.2.6 Market Size Estimation
    16. |-- 2.2.6.1 Bottom-Up Approach
    17. |-- 2.2.6.2 Top-Down Approach
    18. | 2.2.7 Data Triangulation
    19. | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | 3.1.1 Overview
    3. | 3.1.2 Drivers
    4. | 3.1.3 Restraints
    5. | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | 3.2.1 Value chain Analysis
    8. | 3.2.2 Porter's Five Forces Analysis
    9. |-- 3.2.2.1 Bargaining Power of Suppliers
    10. |-- 3.2.2.2 Bargaining Power of Buyers
    11. |-- 3.2.2.3 Threat of New Entrants
    12. |-- 3.2.2.4 Threat of Substitutes
    13. |-- 3.2.2.5 Intensity of Rivalry
    14. | 3.2.3 COVID-19 Impact Analysis
    15. |-- 3.2.3.1 Market Impact Analysis
    16. |-- 3.2.3.2 Regional Impact
    17. |-- 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Treatment Type (USD Billion)
    2. | 4.1.1 Lactase Supplements
    3. | 4.1.2 Probiotics
    4. | 4.1.3 Dietary Modifications
    5. | 4.1.4 Enzyme Replacement Therapy
    6. | 4.2 Healthcare, BY Distribution Channel (USD Billion)
    7. | 4.2.1 Pharmacies
    8. | 4.2.2 Online Retail
    9. | 4.2.3 Supermarkets
    10. | 4.2.4 Health Food Stores
    11. | 4.3 Healthcare, BY Patient Demographics (USD Billion)
    12. | 4.3.1 Children
    13. | 4.3.2 Adults
    14. | 4.3.3 Elderly
    15. | 4.3.4 Pregnant Women
    16. | 4.4 Healthcare, BY Formulation Type (USD Billion)
    17. | 4.4.1 Tablets
    18. | 4.4.2 Powders
    19. | 4.4.3 Liquids
    20. | 4.4.4 Chewables
    21. | 4.5 Healthcare, BY Region (USD Billion)
    22. | 4.5.1 North America
    23. |-- 4.5.1.1 US
    24. |-- 4.5.1.2 Canada
    25. | 4.5.2 Europe
    26. |-- 4.5.2.1 Germany
    27. |-- 4.5.2.2 UK
    28. |-- 4.5.2.3 France
    29. |-- 4.5.2.4 Russia
    30. |-- 4.5.2.5 Italy
    31. |-- 4.5.2.6 Spain
    32. |-- 4.5.2.7 Rest of Europe
    33. | 4.5.3 APAC
    34. |-- 4.5.3.1 China
    35. |-- 4.5.3.2 India
    36. |-- 4.5.3.3 Japan
    37. |-- 4.5.3.4 South Korea
    38. |-- 4.5.3.5 Malaysia
    39. |-- 4.5.3.6 Thailand
    40. |-- 4.5.3.7 Indonesia
    41. |-- 4.5.3.8 Rest of APAC
    42. | 4.5.4 South America
    43. |-- 4.5.4.1 Brazil
    44. |-- 4.5.4.2 Mexico
    45. |-- 4.5.4.3 Argentina
    46. |-- 4.5.4.4 Rest of South America
    47. | 4.5.5 MEA
    48. |-- 4.5.5.1 GCC Countries
    49. |-- 4.5.5.2 South Africa
    50. |-- 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | 5.1.1 Overview
    3. | 5.1.2 Competitive Analysis
    4. | 5.1.3 Market share Analysis
    5. | 5.1.4 Major Growth Strategy in the Healthcare
    6. | 5.1.5 Competitive Benchmarking
    7. | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | 5.1.7 Key developments and growth strategies
    9. |-- 5.1.7.1 New Product Launch/Service Deployment
    10. |-- 5.1.7.2 Merger & Acquisitions
    11. |-- 5.1.7.3 Joint Ventures
    12. | 5.1.8 Major Players Financial Matrix
    13. |-- 5.1.8.1 Sales and Operating Income
    14. |-- 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | 5.2.1 Lactaid (US)
    17. |-- 5.2.1.1 Financial Overview
    18. |-- 5.2.1.2 Products Offered
    19. |-- 5.2.1.3 Key Developments
    20. |-- 5.2.1.4 SWOT Analysis
    21. |-- 5.2.1.5 Key Strategies
    22. | 5.2.2 Danone (FR)
    23. |-- 5.2.2.1 Financial Overview
    24. |-- 5.2.2.2 Products Offered
    25. |-- 5.2.2.3 Key Developments
    26. |-- 5.2.2.4 SWOT Analysis
    27. |-- 5.2.2.5 Key Strategies
    28. | 5.2.3 Nestle (CH)
    29. |-- 5.2.3.1 Financial Overview
    30. |-- 5.2.3.2 Products Offered
    31. |-- 5.2.3.3 Key Developments
    32. |-- 5.2.3.4 SWOT Analysis
    33. |-- 5.2.3.5 Key Strategies
    34. | 5.2.4 Abbott Laboratories (US)
    35. |-- 5.2.4.1 Financial Overview
    36. |-- 5.2.4.2 Products Offered
    37. |-- 5.2.4.3 Key Developments
    38. |-- 5.2.4.4 SWOT Analysis
    39. |-- 5.2.4.5 Key Strategies
    40. | 5.2.5 Pinnacle Foods (US)
    41. |-- 5.2.5.1 Financial Overview
    42. |-- 5.2.5.2 Products Offered
    43. |-- 5.2.5.3 Key Developments
    44. |-- 5.2.5.4 SWOT Analysis
    45. |-- 5.2.5.5 Key Strategies
    46. | 5.2.6 Arla Foods (DK)
    47. |-- 5.2.6.1 Financial Overview
    48. |-- 5.2.6.2 Products Offered
    49. |-- 5.2.6.3 Key Developments
    50. |-- 5.2.6.4 SWOT Analysis
    51. |-- 5.2.6.5 Key Strategies
    52. | 5.2.7 Lactose Free (US)
    53. |-- 5.2.7.1 Financial Overview
    54. |-- 5.2.7.2 Products Offered
    55. |-- 5.2.7.3 Key Developments
    56. |-- 5.2.7.4 SWOT Analysis
    57. |-- 5.2.7.5 Key Strategies
    58. | 5.2.8 Schreiber Foods (US)
    59. |-- 5.2.8.1 Financial Overview
    60. |-- 5.2.8.2 Products Offered
    61. |-- 5.2.8.3 Key Developments
    62. |-- 5.2.8.4 SWOT Analysis
    63. |-- 5.2.8.5 Key Strategies
    64. | 5.2.9 Fonterra (NZ)
    65. |-- 5.2.9.1 Financial Overview
    66. |-- 5.2.9.2 Products Offered
    67. |-- 5.2.9.3 Key Developments
    68. |-- 5.2.9.4 SWOT Analysis
    69. |-- 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | 5.3.1 References
    72. | 5.3.2 Related Reports

Healthcare Market Segmentation

Healthcare By Treatment Type (USD Billion, 2025-2035)

  • Lactase Supplements
  • Probiotics
  • Dietary Modifications
  • Enzyme Replacement Therapy

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Pharmacies
  • Online Retail
  • Supermarkets
  • Health Food Stores

Healthcare By Patient Demographics (USD Billion, 2025-2035)

  • Children
  • Adults
  • Elderly
  • Pregnant Women

Healthcare By Formulation Type (USD Billion, 2025-2035)

  • Tablets
  • Powders
  • Liquids
  • Chewables
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓